Perspective: Ochratoxin A is not a genotoxic carcinogen

Chemical Research in Toxicology

Volumn 18, Issue 7, 2005, Pages 1082-1090

  Turesky, Robert J ^a  

^a WADSWORTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; OCHRATOXIN; REACTIVE OXYGEN METABOLITE;

CARCINOGENESIS; CHEMICAL STRUCTURE; DNA ADDUCT; DNA STRAND BREAKAGE; GENOTOXICITY; INTERSTITIAL NEPHRITIS; MOUSE; MUTAGENICITY; NONHUMAN; OXIDATION; RAT; REVIEW; XENOBIOTIC METABOLISM;

ANIMALS; CARCINOGENS; DNA ADDUCTS; HUMANS; MUTAGENESIS; OCHRATOXINS; OXIDATION-REDUCTION; REACTIVE OXYGEN SPECIES;

EID: 22544479430     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx050076e     Document Type: Review

References (94)

1. van der Merwe, K. J., Steyn, P. S., Fourie, L., Scott, D. B., and Theron, J. J. (1965) Ochratoxin A, a toxic metabolite produced by Aspergillus ochraceus Wilh. Nature 205, 1112-1113.
2. vd, S. G., Jorissen, U., Pittet, A., Saccon, M., Steiner, W., Vincenzi, M., Winkler, M., Zapp, J., and Schlatter, C. (1997) Screening of European coffee final products for occurrence of ochratoxin A (OTA). Food Addit. Contam. 14, 211-216.
3. Kuiper-Goodman, T., and Scott, P. M. (1989) Risk assessment of the mycotoxin ochratoxin A. Biomed. Environ. Sci. 2, 179-248.
4. Kuiper-Goodman, T. (1991) Risk assessment of ochratoxin A residues in food. IARC Sci. Publ. 307-320.
5. Abouzied, M. M., Horvath, A. D., Podlesny, P. M., Regina, N. P., Metodiev, V. D., Kamenova-Tozeva, R. M., Niagolova, N. D., Stein, A. D., Petropoulos, E. A., and Ganev, V. S. (2002) Ochratoxin A concentrations in food and feed from a region with Balkan Endemic Nephropathy. Food Addit. Contam. 19, 755-764.
6. O'Brien, E., and Dietrich, D. R. (2005) Ochratoxin A: The continuing enigma. Crit. Rev. Toxicol. 35, 33-60.
7. World Health Organization (1996) Europe Evaluation of Certain Food Additives and Contaminants, Prepared by the 44th Meeting of the Joint FAO/WHO Expert Committee on Food Additives, WHO Food Additives Series 35, pp 363-376, World Health Organization, Geneva.
8. Boorman, G. A. (1989) National Toxicology Program (NTP) Technical Program on the Toxicology and Carcinogenesis Studies of Ochratoxin A (CAS No. 303-47-9) in F344/N Rats (Gavage Studies), U.S. Department of Health and Human Services, National Institutes of Health, Research Triangle Park, NC.
9. Boorman, G. A., McDonald, M. R., Imoto, S., and Persing, R. (1992) Renal lesions induced by ochratoxin A exposure in the F344 rat. Toxicol. Pathol. 20, 236-245.
10. Castegnaro, M., Bartsch, H., and Chernozemsky, I. N. (1987) Endemic nephropathy and urinary tract tumors in the Balkans. Cancer Res. 47, 3608-3609.
11. Pfohl-Leszkowicz, A., Grosse, Y., Castegnaro, M., Nicolov, I. G., Chernozemsky, I. N., Bartsch, H., Betbeder, A. M., Creppy, E. E., and Dirheimer, G. (1993) Ochratoxin A-related DNA adducts in urinary tract tumours of Bulgarian subjects. IARC Sci. Publ. 141-148.
12. Mantle, P. G., Milijkovic, A., Udupa, V., and Dobrota, M. (1998) Does apoptosis cause renal atrophy in Balkan endemic nephropathy? Lancet 352, 1118-1119.
13. Tatu, C. A., Orem, W. H., Finkelman, R. B., and Feder, G. L. (1998) The etiology of Balkan endemic nephropathy: Still more questions than answers. Environ. Health Perspect. 106, 689-700.
14. IARC (1993) Evaluation of carcinogen risks to humans. Some naturally occurring susbstances: Foods idems and constituants, heterocyclic aromatic amines and mycotoxins. IARC Monographs, Vol. 56, pp 489-521, IARC, Lyon.
15. Dekant, W., and Vamvakas, S. (1996) Biotransformation and membrane transport in nephrotoxicity. Crit. Rev. Toxicol. 26, 309-334.
16. Rasonyi, T., Schlatter, J., and Dietrich, D. R. (1999) The role of alpha2u-globulin in ochratoxin A induced renal toxicity and tumors in F344 rats. Toxicol. Lett. 104, 83-92.
17. Hennig, A., Fink, G. J., and Leistner, L. (1991) Mutagenicity and effects of ochratoxin A on the frequency of sister chromatid exchange after metabolic activation. IARC Sci. Publ. 255-260.
18. Follmann, W., and Lucas, S. (2003) Effects of the mycotoxin ochratoxin A in a bacterial and a mammalian in vitro mutagenicity test system. Arch. Toxicol. 77, 298-304.
19. Malaveille, C., Brun, G., and Bartsch, H. (1994) Structure-activity studies in E. coli strains on ochratoxin A (OTA) and its analogues implicate a genotoxic free radical and a cytotoxic thiol derivative as reactive metabolites. Mutat. Res. 307, 141-147.
20. Dorrenhaus, A., and Follmann, W. (1997) Effects of ochratoxin A on DNA repair in cultures of rat hepatocytes and porcine urinary bladder epithelial cells. Arch. Toxicol. 71, 709-713.
21. Dorrenhaus, A., Flieger, A., Golka, K., Schulze, H., Albrecht, M., Degen, G. H., and Follmann, W. (2000) Induction of unscheduled DNA synthesis in primary human urothelial cells by the mycotoxin ochratoxin A. Toxicol. Sci. 53, 271-277.
22. Creppy, E. E., Kane, A., Dirheimer, G., Lafarge-Frayssinet, C., Mousset, S., and Frayssinet, C. (1985) Genotoxicity of ochratoxin A in mice: DNA single-strand break evaluation in spleen, liver and kidney. Toxicol. Lett. 28, 29-35.
23. 3H]-label from low doses of radioactive ochratoxin A ingested by rats, and evidence for DNA single-strand breaks caused in liver and kidneys. Arch. Toxicol. 58, 219-224.
24. Mally, A., Pepe, G., Ravoori, S., Fiore, M., Gupta, R. C., Dekant, W., and Mosesso, P. (2005) Ochratoxin A causes DNA damage and cytogenic effects, but not DNA adducts in rats. Chem. Res. Toxicol. Accepted for publication.
25. Wurgler, F. E., Friederich, U., and Schlatter, J. (1991) Lack of mutagenicity of ochratoxin A and B, citrinin, patulin and cnestine in Salmonella typhimurium TA102. Mutat. Res. 261, 209-216.
26. Lebrun, S., and Follmann, W. (2002) Detection of ochratoxin A-induced DNA damage in MDCK cells by alkaline single cell gel electrophoresis (comet assay). Arch. Toxicol. 75, 734-741.
27. Obrecht-Pflumio, S., Chassat, T., Dirheimer, G., and Marzin, D. (1999) Genotoxicity of ochratoxin A by Salmonella mutagenicity test after bioactivation by mouse kidney microsomes. Mutat. Res. 446, 95-102.
28. Zepnik, H., Pahler, A., Schauer, U., and Dekant, W. (2001) Ochratoxin A-induced tumor formation: Is there a role of reactive ochratoxin A metabolites? Toxicol. Sci. 59, 59-67.
29. de Groene, E. M., Hassing, I. G., Blom, M. J., Seinen, W., Fink-Gremmels, J., and Horbach, G. J. (1996) Development of human cytochrome P450-expressing cell lines: Application in mutagenicity testing of ochratoxin A. Cancer Res. 56, 299-304.
30. de Groene, E. M., Jahn, A., Horbach, G. J., and Fink-Gremmels, J. (1996) Mutagenicity and genotoxicity of the mycotoxin ochratoxin A. Environ. Toxicol. Pharmacol. 1, 21-26.
31. Stormer, F. C., Hansen, C. E., Pedersen, J. I., Hvistendahl, G., and Aasen, A. J. (1981) Formation of (4R)- and (4S)-4-hydroxyochratoxin A from ochratoxin A by liver microsomes from various species. Appl. Environ. Microbiol. 42, 1051-1056.
32. Stormer, F. C., Storen, O., Hansen, C. E., Pedersen, J. I., and Aasen, A. J. (1983) Formation of (4R)- and (4S)-4-hydroxyochratoxin A and 10-hydroxyochratoxin A from Ochratoxin A by rabbit liver microsomes. Appl. Environ. Microbiol. 45, 1183-1187.
33. Hietanen, E., Malaveille, C., Camus, A. M., Bereziat, J. C., Brun, G., Castegnaro, M., Michelon, J., Idle, J. R., and Bartsch, H. (1986) Interstrain comparison of hepatic and renal microsomal carcinogen metabolism and liver S9-mediated mutagenicity in DA and Lewis rats phenotyped as poor and extensive metabolizers of debrisoquine. Drug Metab. Dispos. 14, 118-126.
34. Gautier, J., Richoz, J., Welti, D. H., Markovic, J., Gremaud, E., Guengerich, F. P., and Turesky, R. J. (2001) Metabolism of ochratoxin A: Aabsence of formation of genotoxic derivatives by human and rat enzymes. Chem Res. Toxicol. 14, 34-45.
35. Funae, Y., and Imaoka, S. (1987) Purification and characterization of liver microsomal cytochrome P-450 from untreated male rats. Biochim. Biophys. Acta 926, 349-358.
36. Zepnik, H., Volkel, W., and Dekant, W. (2003) Toxicokinetics of the mycotoxin ochratoxin A in F 344 rats after oral administration. Toxicol. Appl. Pharmacol. 192, 36-44.
37. Storen, O., Holm, H., and Stormer, F. C. (1982) Metabolism of ochratoxin A by rats. Appl. Environ. Microbiol. 44, 785-789.
38. Gross-Steinmeyer, K., Weymann, J., Hege, H. G., and Metzler, M. (2002) Metabolism and lack of DNA reactivity of the mycotoxin ochratoxin a in cultured rat and human primary hepatocytes. J. Agric. Food Chem 50, 938-945.
39. Xiao, H., Madhyastha, S., Marquardt, R. R., Li, S., Vodela, J. K., Frohlich, A. A., and Kemppainen, B. W. (1996) Toxicity of ochratoxin A, its opened lactone form and several of its analogues: Structure-activity relationships. Toxicol. Appl. Pharmacol. 137, 182-192.
40. Grosse, Y., Monje, M. C., Macé, K., Pfeifer, A., and Pfohl-Leszkowicz, A. (1997) Use of bronchial epithelial cells expressing human cytochrome P450 for study on metabolism and genotoxicity of ochratoxin A. In Vitro Toxicol. 10, 93-102.
41. El, A. C., Pinelli, E., Azemar, B., Zaoui, D., Beaune, P., and Pfohl-Leszkowicz, A. (2000) Phenobarbital increases DNA adduct and metabolites formed by ochratoxin A: Role of CYP 2C9 and microsomal glutathione-S- transferase. Environ. Mol. Mutagen. 35, 123-131.
42. Pfohl-Leszkowicz, A., Grosse, Y., Kane, A., Gharbi, A., Baudrimont, I., Obrecht-Pflumio, S., Creppy, E. E., and Dirheimer, G. (1993) Is the oxidative pathway implicated in the genotoxicity of ochratoxin A? In Human Ochratoxicosis and Its Pathologies (Creppy, E. E., Castegnaro, M., and Dirheimer, G., Eds.) pp 177-187, John Libbey Eurotext Ltd., London, United Kingdom.
43. Schaaf, G. J., Nijmeijer, S. M., Maas, R. F., Roestenberg, P., de Groene, E. M., and Fink-Gremmels, J. (2002) The role of oxidative stress in the ochratoxin A-mediated toxicity in proximal tubular cells. Biochim. Biophys. Acta 1588, 149-158.
44. Gillman, I. G., Clark, T. N., and Manderville, R. A. (1999) Oxidation of ochratoxin A by an Fe-porphyrin system: Model for enzymatic activation and DNA cleavage. Chem. Res. Toxicol. 12, 1066-1076.
45. Dai, J., Park, G., Wright, M. W., Adams, M., Akman, S. A., and Manderville, R. A. (2002) Detection and characterization of a glutathione conjugate of ochratoxin A. Chem. Res. Toxicol. 15, 1581-1588.
46. Dai, J., Wright, M. W., and Manderville, R. A. (2003) Ochratoxin a forms a carbon-bonded C8-deoxyguanosine nucleoside adduct: Implications for C8 reactivity by a phenolic radical. J. Am. Chem. Soc. 125, 3716-3717.
47. Calcutt, M. W., Gillman, I. G., Noftle, R. E., and Manderville, R. A. (2001) Electrochemical oxidation of ochratoxin A: Correlation with 4-chlorophenol. Chem. Res. Toxicol. 14, 1266-1272.
48. Faucet, V., Pfohl-Leszkowicz, A., Dai, J., Castegnaro, M., and Manderville, R. A. (2004) Evidence for covalent DNA adduction by ochratoxin A following chronic exposure to rat and subacute exposure to pig. Chem. Res. Toxicol. 17, 1289-1296.
49. Bolton, J. L., Trush, M. A., Penning, T. M., Dryhurst, G., and Monks, T. J. (2000) Role of quinones in toxicology. Chem. Res. Toxicol. 13, 135-160.
50. Mally, A., Zepnik, H., Wanek, P., Eder, E., Dingley, K., Ihmels, H., Volkel, W., and Dekant, W. (2004) Ochratoxin A: Lack of formation of covalent DNA adducts. Chem. Res. Toxicol. 17, 234-242.
51. Omar, R. F., Hasinoff, B. B., Mejilla, F., and Rahimtula, A. D. (1990) Mechanism of ochratoxin A stimulated lipid peroxidation. Biochem. Pharmacol. 40, 1183-1191.
52. Omar, R. F., Rahimtula, A. D., and Bartsch, H. (1991) Role of cytochrome P-450 in ochratoxin A-stimulated lipid peroxidation. J. Biochem. Toxicol. 6, 203-209.
53. Omar, R. F., Gelboin, H. V., and Rahimtula, A. D. (1996) Effect of cytochrome P450 induction on the metabolism and toxicity of ochratoxin A. Biochem. Pharmacol. 51, 207-216.
54. Gautier, J. C., Holzhaeuser, D., Markovic, J., Gremaud, E., Schilter, B., and Turesky, R. J. (2001) Oxidative damage and stress response from ochratoxin a exposure in rats. Free Radical Biol. Med. 30, 1089-1098.
55. Hoehler, D., Marquardt, R. R., McIntosh, A. R., and Hatch, G. M. (1997) Induction of free radicals in hepatocytes, mitochondria and microsomes of rats by ochratoxin A and its analogues. Biochim. Biophys. Acta 1357, 225-233.
56. Hoehler, D., Marquardt, R. R., McIntosh, A. R., and Xiao, H. (1996) Free radical generation as induced by ochratoxin A and its analogues in bacteria (Bacillus brevis). J. Biol. Chem. 271, 27388-27394.
57. Norblom, G. D., and Coon, M. J. (1977) Hydrogen peroxide formation and stoichiometry of hydroxylation reactions catalyzed by highly purified liver microsomal cytochrome P-450. Arch. Biochem. Biophys. 180, 343-347.
58. Nguyen, N. S. D., Cottet-Maire, F., Buetler, T. M., Lo Russo, A., Krauskopf, A. S., Armstrong, J. M., Vickers, A. E. M., Macé, K., and Rüegg, U. T. (1999) Metabolism-dependent stimulation of reactive oxygen species and DNA synthesis by cyclosporin A in rat smooth muscle cells. Free Radical Biol. Med. 27, 1267-1275.
59. Hoehler, D., and Marquardt, R. R. (1996) Influence of vitamins E and C on the toxic effects of ochratoxin A and T-2 toxin in chicks. Poult. Sci. 75, 1508-1515.
60. Kamp, H. G., Eisenbrand, G., Schlatter, J., Wurth, K., and Janzowski, C. (2005) Ochratoxin A: Induction of (oxidative) DNA damage, cytotoxicity and apoptosis in mammalian cell lines and primary cells. Toxicology 206, 413-425.
61. Meki, A. R., and Hussein, A. A. (2001) Melatonin reduces oxidative stress induced by ochratoxin A in rat liver and kidney. Comp. Biochem. Physiol., Part C: Toxicol. Pharmacol. 130, 305-313.
62. Ozcelik, N., Soyoz, M., and Kilinc, I. (2004) Effects of ochratoxin A on oxidative damage in rat kidney: Protective role of melatonin. J. Appl. Toxicol. 24, 211-215.
63. Luhe, A., Hildebrand, H., Bach, U., Dingermann, T., and Ahr, H. J. (2003) A new approach to studying ochratoxin A (OTA)-induced nephrotoxicity: Expression profiling in vivo and in vitro employing cDNA microarrays. Toxicol. Sci 73, 315-328.
64. Hayes, J. D., and Pulford, D. J. (1995) The glutathione S-transferase supergene family: Regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit. Rev. Biochem. Mol. Biol. 30, 445-600.
65. Berhane, K., Widersten, M., Engstrom, A., Kozarich, J. W., and Mannervik, B. (1994) Detoxication of base propenals and other alpha, beta-unsaturated aldehyde products of radical reactions and lipid peroxidation by human glutathione transferases. Proc. Natl. Acad. Sci. U.S.A. 91, 1480-1484.
66. Grosse, Y., Chekir-Ghedira, L., Huc, A., Obrecht-Pflumio, S., Dirheimer, G., Bacha, H., and Pfohl-Leszkowicz, A. (1997) Retinol, ascorbic acid and alpha-tocopherol prevent DNA adduct formation in mice treated with the mycotoxins ochratoxin A and zearalenone. Cancer Lett. 114, 225-229.
67. Baudrimont, I., Betbeder, A. M., Gharbi, A., Pfohl-Leszkowicz, A., Dirheimer, G., and Creppy, E. E. (1994) Effect of superoxide dismutase and catalase on the nephrotoxicity induced by subchronical administration of ochratoxin A in rats. Toxicology 89, 101-111.
68. Umemura, T., Hasegawa, R., Sai-Kato, K., Nishikawa, A., Furukawa, F., Toyokuni, S., Uchida, K., Inoue, T., and Kurokawa, Y. (1996) Prevention by 2-mercaptoethane sulfonate and N-acetylcysteine of renal oxidative damage in rats treated with ferric nitrilotriacetate. Jpn. J. Cancer Res. 87, 882-886.
69. Pfohl-Leszkowicz, A., Bartsch, H., Azemar, B., Mohr, U., Esteve, J., and Castegnaro, M. (2002) MESNA protects rats against nephrotoxicity but not carcinogenicity induced by ochratoxin A, implicating two separate pathways. Acta Univ. Ser.: Med. Biol. 9, 57-63.
70. Grosse, Y., Castegnaro, M., Macé, K., Bartsch, H., Mohr, U., Dirheimer, G., Pinelli, E., Pfeifer, A., and Pfohl-Leszkowicz, A. (1995) Cytochrome P-450 isoforms implicated in ochratoxin A genotoxicity determined by DNA adduct formation. Clin. Chem. 41, 1927-1929.
71. Obrecht-Pflumio, S., and Dirheimer, G. (2000) In vitro DNA and dGMP adducts formation caused by ochratoxin A. Chem.-Biol. Interact. 127, 29-44.
72. Obrecht-Pflumio, S., and Dirheimer, G. (2001) Horseradish peroxidase mediates DNA and deoxyguanosine 3′-monophosphate adduct formation in the presence of ochratoxin A. Arch. Toxicol. 75, 583-590.
73. Grosse, Y., Baudrimont, I., Castegnaro, M., Betbeder, A. M., Creppy, E. E., Dirheimer, G., and Pfohl-Leszkowicz, A. (1995) Formation of ochratoxin A metabolites and DNA-adducts in monkey kidney cells. Chem.-Biol. Interact. 95, 175-187.
74. Pfohl-Leszkowicz, A., Chakor, K., Creppy, E. E., and Dirheimer, G. (1991) DNA adduct formation in mice treated with ochratoxin A. IARC Sci. Publ. 245-253.
75. Pfohl-Leszkowicz, A., Grosse, Y., Kane, A., Creppy, E. E., and Dirheimer, G. (1993) Differential DNA adduct formation and disappearance in three mouse tissues after treatment with the mycotoxin ochratoxin A. Mutat. Res. 289, 265-273.
76. Schlatter, C., Studer, R. J., and Rasonyi, T. (1996) Carcinogenicity and kinetic aspects of ochratoxin A. Food Addit. Contam. 13 (Suppl.), 43-44.
77. Creppy, E. E., Roschenthaler, R., and Dirheimer, G. (1984) Inhibition of protein synthesis in mice by ochratoxin A and its prevention by phenylalanine. Food Chem. Toxicol. 22, 883-886.
78. Gekle, M., Schwerdt, G., Freudinger, R., Mildenberger, S., Wilflingseder, D., Pollack, V., Dander, M., and Schramek, H. (2000) Ochratoxin A induces JNK activation and apoptosis in MDCK-C7 cells at nanomolar concentrations. J. Pharmacol. Exp. Ther. 293, 837-844.
79. Petrik, J., Zanic-Grubisic, T., Barisic, K., Pepeljnjak, S., Radic, B., Ferencic, Z., and Cepelak, I. (2003) Apoptosis and oxidative stress induced by ochratoxin A in rat kidney. Arch. Toxicol. 77, 685-693.
80. Gekle, M., Sauvant, C., and Schwerdt, G. (2005) Ochratoxin A at nanomolar concentrations: A signal modulator in renal cells. Mol. Nutr. Food Res. 49, 118-130.
81. Pfohl-Leszkowicz, A., Pinelli, E., Bartsch, H., Mohr, U., and Castegnaro, M. (1998) Sex- and strain-specific expression of cytochrome P450s in ochratoxin A-induced genotoxicity and carcinogenicity in rats. Mol. Carcinog. 23, 76-85.
82. Castegnaro, M., Mohr, U., Pfohl-Leszkowicz, A., Esteve, J., Steinmann, J., Tillmann, T., Michelon, J., and Bartsch, H. (1998) Sex- and strain-specific induction of renal tumors by ochratoxin A in rats correlates with DNA adduction. Int. J. Cancer 77, 70-75.
83. Miljkovic, A., Pfohl-Leszkowicz, A., Dobrota, M., and Mantle, P. G. (2003) Comparative responses to mode of oral administration and dose of ochratoxin A or nephrotoxic extract of Penicillium polonicum in rats. Exp. Toxicol. Pathol. 54, 305-312.
84. 32P-postlabeling test for covalent DNA binding of chemicals in vivo: Application to a variety of aromatic carcinogens and methylating agents. Carcinogenesis 5, 231-243.
85. Beranek, D. T. (1990) Distribution of methyl and ethyl adducts following alkylation with monofunctional alkylating agents. Mutat. Res. 231, 11-30.
86. Pfohl-Leszkowicz, A., Grosse, Y., Obrecht, S., Kane, A., Castegnaro, M., Creppy, E. E., and Dirheimer, G. (1993) Preponderance of DNA-adducts in kidney after ochratoxin A exposure. In Human Ochratoxicosis and Its Pathologies (Creppy, E. E., Castegnaro, M., and Dirheimer, G., Eds.) pp 199-207, John Libbey Eurotext Ltd., London, United Kingdom.
87. Roth, A., Chakor, K., Creppy, E. E., Kane, A., Roschenthaler, R., and Dirheimer, G. (1988) Evidence for an enterohepatic circulation of ochratoxin A in mice. Toxicology 48, 293-308.
88. Poirier, M. C., and Beland, F. A. (1992) DNA adduct measurements and tumor incidence during chronic carcinogen exposure in animal models: Implications for DNA adduct-based human cancer risk assessment. Chem. Res. Toxicol. 5, 749-755.
89. Swenberg, J. A., La, D. K., Scheller, N. A., and Wu, K. Y. (1995) Dose-response relationships for carcinogens. Toxicol. Lett. 82-83, 751-756.
90. Anonymous (2005) EU Project 5V0448: Comparison and validation of 32P-postlabeling method. EU project BEQALM, EU project OTA-risk assessment (QLK1-2001-0614) and Report to the European Commission.
91. Koc, H., and Swenberg, J. A. (2002) Applications of mass spectrometry for quantitation of DNA adducts. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 778, 323-343.
92. Turesky, R. J., and Vouros, P. (2004) Formation and analysis of heterocyclic aromatic amine-DNA adducts in vitro and in vivo. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 802, 155-166.
93. Dai, J., Wright, M. W., and Manderville, R. A. (2003) An oxygen-bonded C8-deoxyguanosine nucleoside adduct of pentachlorophenol by peroxidase activation: Evidence for ambident C8 reactivity by phenoxyl radicals. Chem. Res. Toxicol. 16, 817-821.
94. Rahimtula, A. D., Bereziat, J. C., Bussacchini, G. V., and Bartsch, H. (1988) Lipid peroxidation as a possible cause of ochratoxin A toxicity. Biochem. Pharmacol. 37, 4469-4477.